Novartis India files FY26 sustainability report on BSE
- Total energy consumption fell to 290.02 GJ in FY26 from 1,310.0 GJ in FY25
- Scope 2 greenhouse gas emissions dropped to 12.3 metric tonnes CO2e from 277.4 metric tonnes
- Permanent employee turnover rate reached 0% in FY26, down from 7% in FY25
- Board gender diversity stands at 50%, with three women directors out of six
- Regulatory proceedings include a ₹33.83 million income tax appeal and TDS demand
*this image is generated using AI for illustrative purposes only.
Novartis India Limited has submitted its Business Responsibility and Sustainability Report (BRSR) to the Bombay Stock Exchange for the financial year ended March 31, 2026.
The filing outlines the company’s performance against the nine principles of the National Guidelines on Responsible Business Conduct (NGRBC). As a trading entity without manufacturing facilities, Novartis India focuses its disclosures on office operations, supply chain ethics, and stakeholder engagement rather than industrial production metrics.
Operational and Environmental Metrics
The company reported a significant reduction in energy consumption during FY26 compared to the previous year. Total energy consumed fell from 1,310.0 GJ in FY25 to 290.02 GJ in FY26. This decline was driven by a sharp drop in non-renewable electricity consumption, which decreased from 1,310.0 GJ to 60.02 GJ. Renewable electricity consumption was recorded at 230 GJ for the period January 2025 to December 2025.
Greenhouse gas emissions also saw a marked decrease. Total Scope 2 emissions dropped from 277.4 metric tonnes of CO2 equivalent in FY25 to 12.3 metric tonnes in FY26. Scope 1 emissions were not tracked. The reduction in Scope 2 emissions aligns with initiatives such as transitioning local logistics from air to surface freight, which the company states reduced transportation-related emissions by over 70% in 2025 compared to 2024.
Employee Welfare and Governance
Novartis India employed 59 individuals as of March 31, 2026, comprising 57 permanent employees and 2 non-permanent staff. The workforce included 48 males and 11 females. The company reported a 0% turnover rate for permanent employees in FY26, down from 7% in FY25 and 11% in FY24.
The Board of Directors consists of six members, with three women representing 50% of the board. Key Management Personnel includes three individuals, two of whom are female (66.66%). All permanent employees received training on health, safety, and skill upgradation, achieving 100% coverage.
Regulatory and Stakeholder Engagement
The report disclosed several regulatory proceedings. The Income Tax Department proposed an adjustment of approximately ₹33.83 million regarding transfer pricing issues for the assessment year 2022-23; the company has appealed this order. Additionally, a demand of ₹10.28 crore was raised under Section 156 of the Income-tax Act for TDS defaults in AY 2020-21, which is also under appeal.
Stakeholder complaints were minimal. The company received 19 shareholder complaints, with one pending resolution at year-end. Customer complaints totaled 15, with seven pending. No complaints were received regarding sexual harassment, discrimination, or child labour.
What the Numbers Show
The divergence between total waste generated and hazardous waste disposal highlights the operational nature of the entity. While total waste increased from 39.6 metric tonnes in FY25 to 48.9 metric tonnes in FY26, hazardous waste incineration dropped significantly from 36.1 metric tonnes to 17.5 metric tonnes. This suggests a shift in waste composition or improved segregation practices, as plastic waste (26.5 metric tonnes) appeared in FY26 data where it was nil previously.
Historical Stock Returns for Novartis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.23% | +7.75% | +4.19% | 0.0% | 0.0% | +90.61% |
How might the ongoing transfer pricing and TDS appeals impact Novartis India's future tax liabilities and cash flow projections?
Will Novartis India expand its sustainability reporting to include Scope 1 emissions and supply chain (Scope 3) metrics in upcoming filings?
What strategies is Novartis India planning to implement to address the gender disparity in its workforce, given only 11% female representation among permanent employees?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
